A Severe Asthma Roadmap for Improved Diagnosis and Personalized Treatment – A Guided Workflow

Released On
July 13, 2018

Expires On
July 12, 2019

Media Type

Completion Time
120 minutes

Asthma and Allergies


Scroll to the Bottom of this Information to Begin this Course

An educational collaboration with the Mount Sinai - National Jewish Health Respiratory Institute and National Jewish Health.


Supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Novartis Pharmaceuticals Corporation.

Credit Available

  • Physicians — maximum of 2.0 AMA PRA Category 1 Credit(s)
  • ABIM MOC — maximum of 2.0 medical knowledge MOC points.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of allergists, pulmonologists, primary care physicians, pediatricians, physician assistants, advanced practice nurses and registered nurses who treat patients with asthma.

Program Overview

This case-based, interactive, multimedia enduring activity will cover the diagnosis, treatment and management of patients with severe and difficult-to-treat asthma using a test-and-teach simulation-based structure that follows the workflow of our Roadmap Infographic.

Download the infographic here to follow along: Severe Asthma Roadmap PDF (printable on 11x17 paper)

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe key concepts in the pathophysiology of severe asthma and the features that are targets for biologic therapies.
  • Distinguish severe asthma from difficult-to-treat asthma with improved diagnosis and assessment strategies, including proper inhaler technique.
  • Review emerging evidence related to targeted therapies and potential biomarkers to select personalized treatment in severe asthma according to asthma subtype.


Michael E. Wechsler, MD, MMSc

Program Co-Chair
Professor of Medicine
Director of The Cohen Family Asthma Institute
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO

Linda Rogers, MD

Program Co-Chair
Associate Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine
Director, Clinical Asthma Program
Icahn School of Medicine at Mount Sinai
Mount Sinai -- National Jewish Health Respiratory Institute, New York, NY


Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC:Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, A Severe Asthma Roadmap for Improved Diagnosis and Personalized Treatment - A Guided Workflow has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Allergy and Immunology
Family Medicine



In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose all relevant financial relationships with any commercial interest that produces, markets, re-sells or distributes health care goods or services consumed by patients. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

All CME educational activities sponsored by National Jewish Health are reviewed by our CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Michael E. Wechsler, MD, MMSc: Dr. Wechsler discloses that he is a consultant for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Sanofi Regeneron and Teva and an investigator for AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron and Teva.

Linda Rogers, MD: Dr. Rogers discloses that she is a consultant for Teva, on an advisory board and an investigator for Sanofi Regeneron and an educational content developer for AstraZeneca.

Planners and Reviewers

Stephanie Corder, ND, RN has no financial relationships to disclose.

Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.

Aubrey Shoe, MA has no financial relationships to disclose.

Esther Langmack, MD has no financial relationships to disclose.

Anthony N. Gerber, MD, PhD discloses that he is a consultant for Boehringer Ingelheim and Revon Systems.

Kanao Otsu, MD, MPH has no financial relationships to disclose.

Flavia Hoyte, MD discloses that she is an investigator for AstraZeneca, GlaxoSmithKline, Novartis, Regeneron and Teva.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. In order to receive credit for this activity, participants must:

  • Read the educational objectives and faculty disclosures.
  • Participate in the online activity.
  • Complete and submit the evaluation and post-test.

Certificates will be available for download at the end of the activity.


This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

CME Disclaimer

National Jewish Health ("NJH") and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

Contact Information

For CME questions, please contact The Office of Professional Education at National Jewish Health by emailing proed@nationaljewish.org

Contact this CME provider at National Jewish Health for privacy and confidentiality policy statement information at: https://www.nationaljewish.org/about/policies-and-guidelines/privacy-security